Cardio Intervention Devices
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
133
NCT04663867
AngioSafe Peripheral CTO Crossing System Study (RESTOR-1 Study)
Phase: N/A
Role: Lead Sponsor
Start: Feb 3, 2021
Completion: Jun 15, 2023
Loading map...